Bio-Thera And Pharmapark Add Cosentyx Rival To Russia-CIS Collaboration

Secukinumab Biosimilar Expands Deal That Already Includes Golimumab And Ustekinumab

 
• By Dave Wallace
  
Map Of Russia & The Commonwealth Of Independent States
Bio-Thera and Pharmapark have expanded their collaboration in Russia and the CIS • Source: Shutterstock

More from Deals

More from Business